Temasek Holdings
Australia's V2Food raises $55m Series B
Australian alternative protein producer V2Food has raised a A$77 million ($55 million) Series B round featuring Sequoia Capital China and Temasek Holdings.
Temasek restructures asset management entities
Singapore’s Temasek Holdings has created a holding company for its four asset management units – including private equity-focused Azalea Investment Management and venture debt business InnoVen Capital – to provide more support in areas such as third-party...
Genor Biopharma raises $372m in Hong Kong IPO
China-based Genor Biopharma, which counts Hillhouse Capital, Temasek Holdings and Qiming Venture Partners among its investors, has raised HK$2.88 billion ($372 million) through a Hong Kong IPO.
Tiger, Temasek commit $160m to India's Zomato
Tiger Global Management and Temasek Holdings have contributed $160 million to an ongoing Series J round for India-based food delivery company Zomato.
Temasek sees portfolio shrink, ups investment pace
Temasek Holdings has deployed a record S$32 billion ($23.3 billion) in the past year – with technology and healthcare the main beneficiaries – even as the impact of COVID-19 saw its overall portfolio shrink in value for the first time since 2016.
EV Growth, Jungle lead round for Indonesia's Waresix
Indonesian logistics technology provider Waresix has secured about $75 million in Series B funding led by existing backers EV Growth and Jungle Ventures.
Deal focus: KKR's Vietnam macro proxy - update
KKR - working alongside Temasek Holdings - is using Vinhomes as a means to get exposure to Vietnam's booming property market. Mergermarket and AVCJ offer some additional industry context
Asia VC: Vertex's evolving early-stage network
Vertex Holdings’ Chua Kee-Lock likens his network of VC funds seeded by the Temasek-owned entity as a distributed computer system. It will draw down more power as it grows
Wavemaker closes third Southeast Asia fund at $111m
Wavemaker Partners has closed its third Southeast Asia venture capital fund with $111 million in commitments. The target was $100 million.
Ocumension climbs on debut after $184m Hong Kong IPO
Ocumension Therapeutics, a Chinese drug developer targeting eye diseases that counts Boyu Capital and Temasek Holdings among its backers, posted a 152% gain on debut following a HK$1.5 billion ($200 million) Hong Kong IPO.
Indonesia's Social Bella raises $58m Series E
Social Bella, an Indonesian online services provider for the beauty and personal care industry, has raised $58 million in Series E funding.
Singapore's Indies raises $100m for third PE, credit fund
Indies Capital, a Singapore-based GP focused on Indonesia, has reached a first close of $100 million for its third flagship private equity and credit fund.
Deal focus: KKR's Vietnam macro proxy
KKR's investment in Vietnam property developer Vinhomes is supposed to tap into infrastructure development as well as the home-ownership ambitions of a burgeoning middle class
Clifford Capital takes 50% stake in Singapore's Pierfront
Singapore-based infrastructure investor Clifford Capital has acquired a 50% stake in local private credit and mezzanine player Pierfront Capital for an undisclosed sum.
KKR, Temasek commit $650m to Vietnam property developer
A consortium led by KKR has invested VND15.1 trillion ($650 million) in Vinhomes, Vietnam’s leading integrated real estate developer, which went public in 2018.
Singapore's One Championship raises $70m
One Championship, a Singapore-based mixed martial arts (MMA) organization backed by Sequoia Capital India, has raised $70 million in funding.
US-Singapore food tech fund to target Asia
Big Idea Ventures, a US and Singapore-based food technology investor, has launched its debut fund with a target of $50 million. Asia is a core market.
CPE, Mirae lead $100m Series B for China's JW Therapeutics
JW Therapeutics, a China cancer treatment specialist established by Bristol Myers Squibb-owned Juno Therapeutics and China’s WuXi AppTec, has received $100 million in Series B funding.
Hillhouse leads $160m Series B for China's Genor Biopharma
Genor Biopharma, a Shanghai-based innovative drug developer, has raised $160 million in Series B funding led by Hillhouse Capital.
Temasek-owned Fullerton India gets parent funding
Fullerton India Credit (FICC), an Indian non-banking financial company (NBFC) owned by Singapore's Temasek Holdings, has raised INR7.5 billion ($100 million) in funding from its parent.
Singapore's RWDC Industries secures $133m Series B
RWDC Industries, a Singapore-based start-up that is developing fully biodegradable alternatives to single-use plastics, has raised $133 million in Series B funding.
Singapore's Quest Ventures achieves first close for new fund
Quest Ventures, a Singapore-headquartered venture capital firm, has achieved the first close for a new fund. The target for the vehicle is $50 million.
Square Peg joins Series B for Singapore's Doctor Anywhere
Australian VC firm Square Peg Capital has joined a $27 million Series B round for Singapore-based healthcare technology provider Doctor Anywhere.
Temasek, Tencent lead $300m round for China's MiningLamp
MiningLamp Technology, a Chinese big data company, has raised $300 million Series E led by Temasek Holdings and Tencent Holdings. Kuaishou, a local short-video sharing platform backed by Tencent, also took part in the round.